Study to Evaluate Initiation of Stalevo in Early Wearing-off

NCT00462007 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

115

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: Stalevo

Sponsor

Orion Corporation, Orion Pharma